Eliana Pereira De Araújo

Dr. Eliana Pereira De Araújo

University of Campinas (UNICAMP), Campinas, SP, Brazil

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Endocrinology
Verified
Journal Article
Closed access
CSCláudio T. De Souza
Cláudio T. De Souza
Eliana Pereira De AraújoEliana Pereira De Araújo
Eliana Pereira De Araújo
SBSilvana Bordin
Silvana Bordin
RARika Ashimine
Rika Ashimine
RZRicardo Zollner
Ricardo Zollner
LVLício A. Velloso
Lício A. Velloso
Obesity has reached epidemic proportions in several regions of the world. General changes in lifestyle, including consumption of fat-rich food, are among the most important factors leading to an unprecedented increase in the prevalence of this disease. Weight gain results from an imbalance between caloric intake and energy expenditure. Both of these parameters are under the tight control of specialized neurons of the hypothalamus that respond to peripheral anorexigenic and adipostatic signals carried by leptin and insulin. Here we show, by macroarray analysis, that high-fat feeding [hyperlipidic diet (HL)] induces the expression of several proinflammatory cytokines and inflammatory responsive proteins in hypothalamus. This phenomenon is accompanied by increased activation of c-Jun N-terminal kinase and nuclear factor-kappaB. In addition, HL feeding leads to impaired functional and molecular activation of the insulin-signaling pathway, which is paralleled by increased serine phosphorylation of the insulin receptor and insulin receptor substrate-2. Intracerebroventricular treatment of HL rats with a specific inhibitor of c-Jun N-terminal kinase (SP600125) restores insulin signaling and leads to a reduced caloric intake and weight loss. We conclude that HL feeding induces a local proinflammatory status in the hypothalamus, which results in impaired anorexigenic insulin signaling.

25 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Maria Helena Melo LimaMaria Helena Melo Lima
Maria Helena Melo Lima
ACAndréa M. Caricilli
Andréa M. Caricilli
LALélia L. de Abreu
Lélia L. de Abreu
Eliana Pereira De AraújoEliana Pereira De Araújo
Eliana Pereira De Araújo
FPFabiana F. Pelegrinelli
Fabiana F. Pelegrinelli
MSMario Saad
Mario Saad
Background: Wound healing is impaired in diabetes mellitus, but the mechanisms involved in this process are virtually unknown. Proteins belonging to the insulin signaling pathway respond to insulin in the skin of rats. Objective: The purpose of this study was to investigate the regulation of the insulin signaling pathway in wound healing and skin repair of normal and diabetic rats, and, in parallel, the effect of a topical insulin cream on wound healing and on the activation of this pathway. Research Design and Methods: We investigated insulin signaling by immunoblotting during wound healing of control and diabetic animals with or without topical insulin. Diabetic patients with ulcers were randomized to receive topical insulin or placebo in a prospective, double-blind and placebo-controlled, randomized clinical trial (NCT 01295177) of wound healing. Results and Conclusions: Expression of IR, IRS-1, IRS-2, SHC, ERK, and AKT are increased in the tissue of healing wounds compared to intact skin, suggesting that the insulin signaling pathway may have an important role in this process. These pathways were attenuated in the wounded skin of diabetic rats, in parallel with an increase in the time of complete wound healing. Upon topical application of insulin cream, the wound healing time of diabetic animals was normalized, followed by a reversal of defective insulin signal transduction. In addition, the treatment also increased expression of other proteins, such as eNOS (also in bone marrow), VEGF, and SDF-1α in wounded skin. In diabetic patients, topical insulin cream markedly improved wound healing, representing an attractive and cost-free method for treating this devastating complication of diabetes. Trial Registration: ClinicalTrials.gov NCT01295177

1 April 2008 in Journal of Hepatology
Verified
Journal Article
Closed access
DCDennys Esper Cintra
Dennys Esper Cintra
JPJosé R. Pauli
José R. Pauli
Eliana Pereira De AraújoEliana Pereira De Araújo
Eliana Pereira De Araújo
JMJuliana C. Moraes
Juliana C. Moraes
CSCláudio T. de Souza
Cláudio T. de Souza
LVLicio A. Velloso
Licio A. Velloso

3 April 2008 in FEBS Letters
Verified
Journal Article
Closed access
ACAndressa Coope
Andressa Coope
MMMarciane Milanski
Marciane Milanski
Eliana Pereira De AraújoEliana Pereira De Araújo
Eliana Pereira De Araújo
MTMarcos Tambascia
Marcos Tambascia
MSMário J.A. Saad
Mário J.A. Saad
LVLício A. Velloso
Lício A. Velloso

1 July 2009 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
ECEverardo M. Carneiro
Everardo M. Carneiro
MLMarcia Q. Latorraca
Marcia Q. Latorraca
Eliana Pereira De AraújoEliana Pereira De Araújo
Eliana Pereira De Araújo
MBMarta Beltrá
Marta Beltrá
MOMaría-Jesús Oliveras-López
María-Jesús Oliveras-López
FMFranz Martín
Franz Martín

1 July 2018 in Acta Biomaterialia
Verified
Journal Article
Closed access
Mathilde ChampeauMathilde Champeau
Mathilde Champeau
VPValéria Póvoa
Valéria Póvoa
LMLucas Militão
Lucas Militão
FCFlávia M. Cabrini
Flávia M. Cabrini
GPGuilherme F. Picheth
Guilherme F. Picheth
MOMarcelo G. De Oliveira
Marcelo G. De Oliveira